Form D · Pharmaceuticals
CEPTARIS THERAPEUTICS, INC
Malvern, PA · CIK 0001175706
Offering snapshot reported May 22, 2012 · SEC filing
- Reported sold
- $8.29M Offering amount: $10M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $185 Reported outside-investor minimum
- First sale
- May 14, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2012 | Initial | $8,292,176 | No comparison | 33 | SEC filing |
| Aug 17, 2011 | Initial | $8,150,000 | No comparison | 30 | SEC filing |
| Nov 22, 2010 | Initial | $2,000,000 | No comparison | 27 | SEC filing |
| Aug 18, 2009 | Initial | $3,140,000 | No comparison | 6 | SEC filing |
| Nov 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 27, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-178599
Source: Form D, filed May 22, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kamil Ali Jackson | Executive |
| Robert J. Alonso | Director, Executive |
| Albert Cha | Director |
| Evan Dick | Executive |
| John Doux | Director |
| David Drahams | Director |
| David C. Drahms | Director |
| Doug Gessl | Executive |
| Douglas Gessl | Executive |
| William Hamilton | Director |
| Timothy Henkel | Executive |
| Thomas P. Hess | Executive |
| James Huang | Director |
| Stephen Tullman | Director, Executive |
| Greg Vontz | Director |
| H. Jeffrey Wilkins | Executive |
| Jeff Wilkins | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
101 Lindenwood Drive Suite 400
Malvern, PA, 19355
Malvern, PA, 19355